The GPAA1 gene helps attach certain proteins to the outer surface of cells, where they do their jobs. This gene plays an important role in helping cells send signals and develop normally, especially in the brain. If the gene does not work properly, some proteins cannot stay anchored to the cell surface. More disruptive variants in both copies of the GPAA1 gene can cause a rare inherited condition linked to developmental delay, low muscle tone, seizures, and brain changes on scans.

What is a gene?

Genes are stretches of DNA that carry instructions your cells use to make molecules or to guide processes throughout the body. Some genes provide the directions for producing proteins, which are the active parts of cells. Others are mainly involved in regulating when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they may influence how you react to food, stress, or medicines. For a deeper look at this topic, you can find more in LearnHub.

Overview

GPAA1

Gene function

What if the gene works

The GPAA1 gene helps cells attach certain proteins to the outer cell surface using GPI anchors, which act like molecular tethers. This helps many proteins stay in the right place and do their jobs.

Risk

What if the gene does not work

More disruptive variants in the GPAA1 gene can cause a condition that often leads to developmental delay, low muscle tone, seizures, and cerebellar changes on brain scans. Milder variants may cause later onset or less severe features.

Treatment

What does that mean for your treatment

No treatment or drug choice is currently guided specifically by a pathogenic variant in the GPAA1 gene. Care is based on the person’s symptoms and supportive management, not on a GPAA1-specific medicine or guideline-directed therapy.

Conditions associated with GPAA1

Neurodevelopmental delay-seizures-ophthalmic anomalies-osteopenia-cerebellar atrophy syndrome

Gene function

What if the gene works

Many cells need certain proteins to work on their outer surface. The GPAA1 gene helps with this final setup step by attaching a GPI anchor (a fatty tag that tethers a protein to the cell membrane). Understanding what the GPAA1 gene does in your cells helps explain how proteins reach the cell surface and stay in place.

Anchor attachment

Inside your cells, the GPAA1 gene helps place a GPI anchor (a fatty tag that holds a protein at the cell surface) onto selected proteins. This gives those proteins the membrane attachment they need before they move to the outside of the cell.

Surface delivery

Once the anchor is attached, many proteins can travel to the cell surface and stay there. This supports normal cell communication and other everyday tasks that depend on surface proteins.

Protein finishing

GPAA1 works as part of a small protein team that prepares certain proteins during their final processing. By doing this, it helps cells display the right tools on their outer surface.

What is a variant?

A genetic variant is a small alteration in the DNA sequence of a gene. These changes are common and are part of normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change a gene’s function more significantly and may contribute to, or cause, a genetic condition.

Variant illustration

Genetic variants

What if the gene does not work

GPAA1 gene variants can reduce or block the cell’s ability to attach certain proteins to its outer surface, often by changing the protein’s shape, stability, or ability to work with partner proteins. In how GPAA1 gene variants affect protein anchoring, milder missense variants may leave some activity, while more disruptive variants can lead to very little or none. This functional range can influence how early features appear and how strongly the condition affects development and seizures.

How variants are linked to conditions

Pathogenic variants in both copies of the GPAA1 gene cause a rare inherited neurodevelopmental condition. People with GPAA1 gene variants linked to this condition often have developmental delay, low muscle tone, and seizures, and some also show cerebellar atrophy on brain scans. Features can vary from person to person.

A variant is not necessarily a diagnosis

Variants in DNA are a usual feature of human biology and are widely found across the general population. Most do not directly affect health and simply reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when more than one gene and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.

Dr. Wallerstorfer Dr. Wallerstorfer

Are there things that can increase or change my risk?

For GPAA1, risk is mainly shaped by inheritance rather than lifestyle. A child is at risk only if both biological parents carry a harmful GPAA1 variant, so family history, known carrier status, and parents being blood relatives can raise the chance in a family.

Inheritance of GPAA1 variants

GPAA1-related conditions are inherited in an autosomal recessive pattern. In practical terms, how GPAA1 variants are inherited usually means a child needs to receive one altered copy of the GPAA1 gene from each parent to be affected. Parents who each carry one variant are usually unaffected themselves, and with each pregnancy there is a 25% chance the child will inherit both variants, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant.

What does my GPAA1 result mean for my family?

GPAA1-related conditions are passed down in a recessive pattern, so family members are most often healthy carriers unless they have two changed copies of the gene. Brothers and sisters of an affected child may also be affected or may be carriers, and other relatives may be carriers as well. For parents, this usually means each future pregnancy has the same chance of having a child with the condition.


Genetic information


Genetic testing

How you find out about variants

To look for variants in the GPAA1 gene, doctors use genetic testing on a blood or saliva sample. This genetic testing for GPAA1 gene variants usually reads the gene’s DNA as part of a multi-gene panel or exome test and can show whether a variant is present. Results are interpreted alongside symptoms and family history.

When should I consider getting a genetic test?

Genetic testing may be worth considering when a child has unexplained developmental delay, seizures, low muscle tone, or certain changes on a brain scan, especially if similar problems run in the family. Testing can help show whether changes in the GPAA1 gene are the cause.

A genetic result is only one part of your health story

A genetic finding can provide useful insight, but what it tells you varies depending on the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body works over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can help make sense of individual experiences.

Dr. Wallerstorfer Dr. Wallerstorfer

Pharmacogenetics

How variants shape your response to medicine

Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is absorbed, broken down, transported, or acts in the body, so the same treatment may work better for one person than for another. This is common and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.

What is Pharmacogenetics?

Pharmacogenetics examines how genetic differences can shape a person’s response to medications. It studies links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug affects the body and how the body processes it. This information can support more informed and more personalized treatment decisions. You can read more about this topic in the LearnHub.


Drugs influenced by the GPAA1 gene

There are 0 Drugs associated with GPAA1
Currently no available information

When should I seek medical advice?

There is not yet a broadly confirmed role for this gene in how people respond to medicines, so questions about side effects, medication choices, or new symptoms are best discussed with your doctor.

DISCLAIMER: The materials present on Genopedia.com, such as text, images, graphics, among other items (“Content”), are shared purely for informational reasons. This content should not replace professional health advice, medical diagnoses, or treatment procedures. Whenever you have health concerns or questions, it’s always recommended to engage with your doctor or another appropriate healthcare provider. If you read something on the Genopedia.com site, do not neglect professional medical counsel or delay in obtaining it. In case you believe you’re dealing with a medical crisis, get in touch with your medical professional or call emergency without delay. Genopedia.com doesn’t advocate for any particular medical tests, healthcare providers, products, methods, beliefs, or other data that could be discussed on the site. Please also note that the content, originally written in English and in part created with the help of artificial intelligence, is provided without any warranty, and any reliance on information offered by Genopedia.com, its staff, contributors invited by Genopedia.com, or site users is entirely at your own risk.
Genopedia © 2026 all rights reserved